zyrtec sinus pressure
PARIS, March 31, 2021 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has approved Sarclisa (isatuximab-irfc) in combination with
Read more
Triplet Therapy Slows Refractory Multiple Myeloma
WEDNESDAY, Nov. 18, 2020 — A once-weekly regimen of selinexor, bortezomib, and dexamethasone slows the progression of relapsed or refractory
Read more